Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaChaolin Huang, Bin Cao, Ting Yu et al.|The Lancet|2020Cited by 51.8k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19Bin Cao, Chunmin Jia, Yeming Wang et al.|New England Journal of Medicine|2020Cited by 5.5k
Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trialJia Liu, Luqi Huang, Wei Yang et al.|Phytomedicine|2021Cited by 71
Tetrahydroxy stilbene glycoside ameliorates neuroinflammation for Alzheimer's disease via cGAS-STINGDan Gao, Boya Li, Ceng-ceng Zheng et al.|European Journal of Pharmacology|2023Cited by 64
Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trialNannan Shi, Luqi Huang, Lanping Guo et al.|Phytomedicine|2020Cited by 59